Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone. | CureHunter

HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone.

Authors	Michael B Sporn, Waun Ki Hong
Journal	Cancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 1 Issue 1 Pg. 9-11 (Jun 2008) ISSN: 1940-6215 [Electronic] United States
PMID	19138930 (Publication Type: Comment, Journal Article)
Chemical References	Sulindac Eflornithine
Topics	Adenoma (pathology) Antineoplastic Combined Chemotherapy Protocols (therapeutic use) Clinical Trials as Topic Colorectal Neoplasms (pathology) Eflornithine (administration & dosage) Humans Neoplasm Recurrence, Local (prevention & control) Sulindac (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!